EricLawrenceEisenhauerMD

Obstetrics & Gynecology • Boston, MA

Gynecologic Oncology

Chief, Division of Gynecologic Oncology, Massachusetts General Hospital

Join to view full profile

Dr. Eisenhauer is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Eisenhauer's full profile

Already have an account?

Office
55 Fruit St
Boston, MA 02114
Phone+1 617-724-4800

Fax+1 617-724-6009

Education & Training

Memorial Sloan Kettering Cancer CenterFellowship, Gynecologic Oncology, 2004 - 2008
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Obstetrics and Gynecology, 2000 - 2004
University of California San Diego School of MedicineClass of 2000

Certifications & Licensure

MA State Medical License 2018 - 2025
OH State Medical License 2008 - 2019
NY State Medical License 2004 - 2010
American Board of Obstetrics and Gynecology Obstetrics & Gynecology
American Board of Obstetrics and Gynecology Gynecologic Oncology

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
Active, not recruiting
Phase 3
Elesclomol Sodium and Paclitaxel in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer Start of enrollment: 2010 Dec 13
Completed
Phase 2
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery Start of enrollment: 2010 Apr 12
Active, not recruiting
Phase 3
Paclitaxel and Carboplatin With or Without Metformin Hydrochloride in Treating Patients With Stage III, IV, or Recurrent Endometrial Cancer Start of enrollment: 2014 Mar 17
Active, not recruiting
Phase 2, Phase 3
Trametinib in Treating Patients With Recurrent or Progressive Low-Grade Ovarian Cancer or Peritoneal Cavity Cancer Start of enrollment: 2014 Feb 27
Active, not recruiting
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

1 citations
The association of maintenance hormone therapy with overall survival in advanced-stage low-grade serous ovarian carcinoma: A risk-set matched retrospective study.
Syem K Barakzai, Amy J Bregar, Marcela G Del Carmen, Eric L Eisenhauer, Annekathryn Goodman
Gynecologic Oncology. 2024-11-01
2 citations
NCCN Guidelines® Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024.
Joyce Liu, Andrew Berchuck, Floor J Backes, Joshua Cohen, Rachel Grisham
Journal of the National Comprehensive Cancer Network. 2024-10-01
Genomic Discovery and Structure-Activity Exploration of a Novel Family of Enzyme-Activated Covalent Cyclin-Dependent Kinase Inhibitors.
Jack R Davison, Michalis Hadjithomas, Stuart P Romeril, Yoon Jong Choi, Keith W Bentley
Journal of Medicinal Chemistry. 2024-08-08

Press Mentions

Lymphadenectomy in Advanced Ovarian Cancer: Will It Improve Survival?March 19th, 2019
Lymphadenectomy Often Useless in Ovarian CancerMarch 1st, 2019
Dr. Eric L. Eisenhauer Has Been Recognized Among the Top in His Industry by the Expert Network©January 21st, 2016

Professional Memberships

Society of Gynecologic Oncology
Member